Power Law company profile

Prime Medicine

Biotech & Life Sciences · Cambridge, United States · Founded 2019 · IPO 2022 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$576M

Market cap · Apr/2026

Revenue

$4.6M

Latest reported FY

Investors

5 investors on Prime Medicine's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

ARCH Venture Partners

Arrive Roc Nation

Newpath Management

F-Prime

Series B+ 1 investor entered at this stage

Casdin Capital

Global footprint

Where Prime Medicine has talent and traffic

AI talent share

0.5% of workforce is AI talent
(1 of 185 staff)

Core AI00%

Other AI10.54%

Non-AI workforce18499.46%

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States59.3%

🇬🇧 United Kingdom13.6%

🇮🇳 India9.3%

🇨🇦 Canada5.7%

🇧🇷 Brazil4.3%

Top 5 markets shown

Patent intelligence

$562k patent portfolio · 28 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$562k

0.10% of market cap · 4855.4× smaller than top peer Illumina ($2.7B)

28 active patent families

Where Prime Medicine innovates Genetic disorderMolecular biologyBioinformaticsGenome editingGuide RNA

Below peer median on Legal, Market

Quality vs same-sector peers

Prime Medicine on the five Patsnap quality dimensions

Prime Medicine in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Prime Medicine concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Prime Medicine and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Prime Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo